MX2016004406A - Derivados de 1,4-ciclohexilamina y proceso para la preparacion de los mismos. - Google Patents

Derivados de 1,4-ciclohexilamina y proceso para la preparacion de los mismos.

Info

Publication number
MX2016004406A
MX2016004406A MX2016004406A MX2016004406A MX2016004406A MX 2016004406 A MX2016004406 A MX 2016004406A MX 2016004406 A MX2016004406 A MX 2016004406A MX 2016004406 A MX2016004406 A MX 2016004406A MX 2016004406 A MX2016004406 A MX 2016004406A
Authority
MX
Mexico
Prior art keywords
preparation
processes
cyclohexylamine derivatives
cariprazine
synthesis
Prior art date
Application number
MX2016004406A
Other languages
English (en)
Other versions
MX361183B (es
Inventor
Taddei Maurizio
Cini Elena
Rasparini Marcello
Original Assignee
Chemo Res S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Res S L filed Critical Chemo Res S L
Publication of MX2016004406A publication Critical patent/MX2016004406A/es
Publication of MX361183B publication Critical patent/MX361183B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/26Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/033Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a un proceso para la síntesis de Cariprazina, un compuesto antipsicótico útil en el tratamiento de síntomas positivos y negativos asociados con esquizofrenia, con la siguiente fórmula estructural: (A) La invención se refiere además, a la síntesis de intermediarios útiles en la preparación de Cariprazina.
MX2016004406A 2013-10-14 2014-10-14 Derivados de 1,4-ciclohexilamina y procesos para la preparación de los mismos. MX361183B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI20131693 ITMI20131693A1 (it) 2013-10-14 2013-10-14 Derivati della 1,4-cicloesilammina e loro preparazione
PCT/IB2014/065293 WO2015056164A1 (en) 2013-10-14 2014-10-14 1,4-cyclohexylamine derivatives and processes for the preparation thereof

Publications (2)

Publication Number Publication Date
MX2016004406A true MX2016004406A (es) 2016-10-12
MX361183B MX361183B (es) 2018-11-29

Family

ID=49640014

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016004406A MX361183B (es) 2013-10-14 2014-10-14 Derivados de 1,4-ciclohexilamina y procesos para la preparación de los mismos.

Country Status (10)

Country Link
US (1) US9718795B2 (es)
EP (1) EP3057942B1 (es)
ES (1) ES2640137T3 (es)
HR (1) HRP20171172T1 (es)
IL (1) IL245101B (es)
IT (1) ITMI20131693A1 (es)
MX (1) MX361183B (es)
PL (1) PL3057942T3 (es)
SI (1) SI3057942T1 (es)
WO (1) WO2015056164A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2317852T1 (sl) 2008-07-16 2015-04-30 Richter Gedeon Nyrt. Farmacevtske formulacije, ki vsebujejo ligande dopaminskega receptorja
CN105330616B (zh) * 2015-12-09 2017-09-26 苏州明锐医药科技有限公司 卡利拉嗪的制备方法
HU231173B1 (hu) 2016-07-08 2021-06-28 Richter Gedeon Nyrt. Ipari eljárás cariprazine előállítására
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
WO2018229794A1 (en) * 2017-06-13 2018-12-20 Cipla Limited Amorphous form of cariprazine
WO2019016828A1 (en) * 2017-07-15 2019-01-24 Msn Laboratories Private Limited, R&D Center NOVEL PROCESSES FOR THE PREPARATION OF TRANS-N- {4- [2- [4- (2,3-DICHLOROPHENYL) PIPERAZIN-1-YL] ETHYL] CYCLOHEXYL} -N ', N'-DIMETHYLUMED HYDROCHLORIDE AND POLYMORPHS THIS ONE
WO2019106490A1 (en) * 2017-12-01 2019-06-06 Aurobindo Pharma Limited A process for the preparation of cariprazine hydrochloride
CN108586389B (zh) * 2018-06-29 2020-06-12 成都福柯斯医药技术有限公司 一种合成卡利拉嗪的方法
CN110818678B (zh) * 2018-08-14 2022-04-01 浙江京新药业股份有限公司 一种制备环己烷衍生物的方法
CN110818677A (zh) * 2018-08-14 2020-02-21 浙江京新药业股份有限公司 环己烷衍生物的制备方法
WO2020034946A1 (zh) * 2018-08-14 2020-02-20 浙江京新药业股份有限公司 一种制备环己烷衍生物的方法
CN110818680A (zh) * 2018-08-14 2020-02-21 浙江京新药业股份有限公司 一种环己烷衍生物的制备方法
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder
JP2023501306A (ja) * 2019-11-05 2023-01-18 上▲海▼翰森生物医▲薬▼科技有限公司 ベンゾチオフェン誘導体レギュレーター、その調製法及び使用
US11344503B2 (en) * 2019-12-13 2022-05-31 Halo Science LLC Cariprazine release formulations
CN113527227B (zh) * 2020-04-15 2024-06-21 四川弘远药业有限公司 一种卡利拉嗪的制备方法
CN113912565A (zh) * 2020-07-11 2022-01-11 广东东阳光药业有限公司 一种卡利拉嗪的新晶型及其制备方法
HUP2100108A1 (hu) 2021-03-12 2022-09-28 Richter Gedeon Nyrt Eljárás és berendezés gyógyászatilag alkalmazható piperazin származékok folyamatos áramú, áramlásos konszekutív redukálással történõ elõállítására
CN115806510B (zh) * 2023-02-03 2023-04-21 成都福柯斯医药技术有限公司 3-反式-4-(2-羟乙基)环己基-1,1-二甲基脲的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227543B1 (en) 2001-09-28 2011-08-29 Richter Gedeon Nyrt N-[4-(2-piperazin- and 2-piperidin-1-yl-ethyl)-cyclohexyl]-sulfon- and sulfamides, process for their preparation, their use and pharmaceutical compositions containing them
HU227534B1 (en) * 2003-08-04 2011-08-29 Richter Gedeon Nyrt (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them
HU229858B1 (en) 2008-12-17 2014-10-28 Richter Gedeon Nyrt Process for the preparation of trans 4-amino-cyclohexyl acetic acid ethyl ester hcl
HU230067B1 (hu) * 2008-12-17 2015-06-29 Richter Gedeon Nyrt Új piperazin só és eljárás előállítására

Also Published As

Publication number Publication date
ITMI20131693A1 (it) 2015-04-15
EP3057942B1 (en) 2017-06-14
SI3057942T1 (sl) 2017-11-30
HRP20171172T1 (hr) 2017-10-20
IL245101B (en) 2018-07-31
US9718795B2 (en) 2017-08-01
EP3057942A1 (en) 2016-08-24
IL245101A0 (en) 2016-06-30
WO2015056164A1 (en) 2015-04-23
ES2640137T3 (es) 2017-10-31
PL3057942T3 (pl) 2018-01-31
US20160257661A1 (en) 2016-09-08
MX361183B (es) 2018-11-29

Similar Documents

Publication Publication Date Title
MX361183B (es) Derivados de 1,4-ciclohexilamina y procesos para la preparación de los mismos.
PH12015501843A1 (en) Novel pyrazol derivatives
EA030383B9 (ru) Бициклически замещённые урацилы, способы их получения, их применение, лекарственное средство и способ лечения с их применением
PH12015501960A1 (en) Processes for the preparation of an apoptosis-inducing agent
PH12015502471A1 (en) Purine derivatives as cb2 receptor agonists
NZ711192A (en) Process for making benzoxazepin compounds
MX2020005079A (es) Derivados de aminotiazol utiles como agentes antiviricos.
PH12017500747A1 (en) Heterocyclic compound
PH12014501195A1 (en) Novel 2h-indazoles as ep2, receptor antagonists
SG10201900541QA (en) Derivatives of xanthone compounds
IN2014DN06964A (es)
MX350122B (es) Tinturas dispersas, su preparación y su uso.
MY191759A (en) Processes for the preparation of pyrimidinylcyclopentane compounds
MX348841B (es) Derivados de pirimidooxazocina como inhibidores de mtor.
IN2013MU01290A (es)
IN2013MU04056A (es)
MX2015011881A (es) Proceso para la preparacion de 3,7-dimetilnonan-1-ol.
IN2013MU02748A (es)
MX2016005220A (es) Tinturas acidas, proceso para su produccion y su uso.
MX2016005222A (es) Tinturas acidas, proceso para su produccion y su uso.
IN2013MU00777A (es)
MX361888B (es) Un procedimiento mejorado para producir zilpaterol.
IN2014DN07498A (es)
MX2018009943A (es) Proceso para la fabricacion de derivados de 3-piperazin-1-il-propi lamina.
MX2016005221A (es) Tinturas acidas, proceso para su produccion y su uso.

Legal Events

Date Code Title Description
FG Grant or registration